person

Alberto G. I.

Country
Spain
Department
Gynecology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 6 partner sites.

Specializations

Gynecologic Oncology

Focuses on malignancies of the female reproductive system, including Endometrial Carcinoma, Cervical Squamous Cell Carcinoma, Vulvar Squamous Cell Carcinoma, and advanced ovarian neoplasms.

  • Targeted therapies for endometrial cancer
  • Immunotherapy in cervical cancer
  • Biomarker‑driven trials in ovarian carcinoma

Emphasizes integration of molecular profiling to personalize treatment strategies.

Hematologic Malignancies

Involvement in disorders such as Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, and various lymphomas.

  • Novel agents for AML
  • B‑cell lymphoma targeted treatments
  • Combination regimens for multiple myeloma

Collaborates closely with transplant programs to optimize therapeutic outcomes.

Advanced Solid Tumor Immunotherapy

Engages in studies of checkpoint inhibition and antibody‑drug conjugates across Non‑Small Cell Lung Cancer, Metastatic Breast Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.

  • PD‑L1 blockade in NSCLC
  • HER2‑targeted ADCs in breast cancer
  • Combination immunotherapy in RCC

Prioritizes biomarker‑selected patient cohorts for precision immunotherapy.

Metabolic and Cardiovascular Disease

Addresses conditions such as Obesity‑related sleep apnea, Atherosclerotic Cardiovascular Disease, and Hyperlipidemia.

  • Therapeutic strategies for OSA in obesity
  • Lipid‑lowering interventions in ASCVD
  • Blood pressure management in resistant hypertension

Leverages interdisciplinary links with endocrinology and cardiology.

Rare Genetic and Pediatric Disorders

Investigates inherited and rare diseases including Alport syndrome, Neurofibromatosis Type 1, and metabolic deficiencies like Glycogen Storage Disease Type Ia.

  • Gene‑targeted therapies for Alport syndrome
  • MEK inhibition in NF1‑associated tumors
  • Enzyme replacement approaches for GSD Ia

Partners with genetics clinics to advance pediatric therapeutic options.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.